Lindbrook Capital, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Lindbrook Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$17.63 - $21.74 $35 - $43	2 Added 0.3%	660 $13,000
Q4 2023 Jan 31, 2024	BUY	$14.37 - $19.07 $704 - $934	49 Added 8.05%	658 $11,000
Q3 2023 Oct 25, 2023	BUY	$13.62 - $20.2 $394 - $585	29 Added 5.0%	609 $10,000
Q1 2023 Apr 26, 2023	BUY	$10.7 - $15.79 $1,316 - $1,942	123 Added 26.91%	580 $6,000
Q4 2022 Jan 24, 2023	SELL	$11.42 - $17.05 $296 - $443	-26 Reduced 5.38%	457 $0
Q3 2022 Nov 10, 2022	BUY	$9.76 - $13.41 $4,489 - $6,168	460 Added 2000.0%	483 $6,000
Q2 2022 Aug 01, 2022	BUY	$7.6 - $11.41 $174 - $262	23 New	23 $0

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.